Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IP Cisplatin + IV Paclitaxel NACT in Advanced Ovarian Cancer
NCT04885270Phase 3Unknown
- Sponsor
- West China Second University Hospital
- Start
- Aug 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin in ovarian cancer, sponsored by West China Second University Hospital. Status: unknown.
02
Drugs
cisplatin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT04885270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04885270.